The global Fc fusion protein market size reached USD 26.97 Billion in 2020 and is expected to register a revenue CAGR of 10.5% during the forecast period, according to latest analysis by Emergen Research. Increased use of Fc fusion protein for vaccines such as Filovirus vaccines is expected to boost market growth going ahead. In rabbits, mice, and monkeys, the immunogenicity of a CHO-expressed recombinant SARS-CoV-2 S1-Fc fusion protein as a potential COVID-19 vaccine option was studied. The immunogenicity of the S1-Fc fusion protein is strong. Using a pseudovirus neutralization assay, rabbits vaccinated with the S1-Fc fusion protein demonstrated significant viral neutralizing activity.
The study aims to provide a forecast of the growth of the Fc Fusion Protein market by examining the market size, share, demand, trends, and gross revenue of the industry. Further, it provides a competitive analysis and SWOT analysis. The report segments the industry based on product type, application and end-use. It highlights the emerging trends as well as the novel technology that are visible in the market. The research offers a clear look at the trends observed in the market, the contributing factors, major stakeholders, key companies and prime areas that exhibit a potential for growth.
To know more about the report, visit @https://www.emergenresearch.com/industry-report/fc-fusion-protein-market
The report is updated with the latest economic scenario and market scope with regard to the ongoing COVID-19 pandemic. The report covers growth prospects as well as current and futuristic revenue estimations in a post COVID scenario. The report also covers changing trends and market dynamics due to the pandemic and provides an accurate impact analysis of the crisis on the overall market.
Get a sample of the report @https://www.emergenresearch.com/request-sample/816
Leading Companies of the Fc Fusion Protein Industry and Profiled in the Report are:
Sanofi S.A., Bristol-Myers Squibb Company, Amgen Inc., Pfizer Inc., Swedish Orphan Biovitrum AB, Eli Lilly and Company, Astellas Pharma Inc., Bayer AG, Regeneron Pharmaceuticals, Inc., and 3SBio Inc.
Emergen Research has segmented the global Fc fusion protein on the basis of type, therapeutic area, application, end-use, and region:
Type Outlook (Revenue, USD Billion; 2018–2028)
- Biosimilar Drugs
- Brands Drugs
Therapeutic Area Outlook (Revenue, USD Billion; 2018–2028)
- Eye Diseases
- Hemophilia
- Autoimmune Disease
- Diabetes
- Others
Application Outlook (Revenue, USD Billion; 2018–2028)
- In Vitro
- Immunohistochemistry
- Flow Cytometry
- Binding Assays
- Microarray Technologies
- In Vivo
- Bio-therapeutic Drugs
End-Use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals
- Ophthalmic Hospitals
- Oculoplastic Clinics
Regional Analysis:
The report sheds light on the region expected to dominate the Fc Fusion Protein market in the coming years. The report estimates the market size in terms of volume and value and offers an accurate estimate of the market share each region is anticipated to hold during the forecast period. The report analyzes the spread of the Fc Fusion Protein market in key geographies covering North America, Latin America, Europe, Asia Pacific, and Middle East Africa. The regional analysis offers an idea about the production and consumption pattern, import/export, supply and demand ratio, revenue contribution, market share and size, and the presence of prominent players in each region.
Request customization of the report @https://www.emergenresearch.com/request-for-customization/816
Thank you for reading our report. Customization of this report is available in chapter-wise or region-wise sections. Kindly get in touch with us to know more about the report, and our team will provide excellent assistance.
Read similar reports by Emergen Research:
Crop Monitoring Market
Biological Wastewater Treatment Market
Seed Processing Market
Artificial Intelligence In Food And Beverage Market
Smart Kitchen Appliances Market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
